Abstract:Objective To study the effects of extracellular-signal regulated kinase mitogenactivated protein kinase (ERK-MAPK) signaling pathway inhibition on histone phosphorylation and the related gene expression in human colorectal cancer cells.Methods Two human colorectal cancer cell lines (SW1116 and HCT116) were cultured and treated with gradient(0,20,40/μmol/L) doses of ERK-MAPK signaling pathway inhibitor U0126.Cell viability was determined by cell counting kit 8 (CCK-8) assay.Cell cycle distribution was assessed by flow cytometry.The expression levels of histone H3 kinases including ribosomal S6 serine-threonine kinase (RSK-2) and mitogen-and stressactivated protein kinase 1 and 2 (MSK1 and MSK2),and the levels of histone H3 (Ser10) phosphorylation and c-Fos protein were detected using Western blotting.Results Treatment of these two human colorectal cancer cell lines with ERK-MAPK inhibitor resulted in a time and dose-dependent inhibition of cell proliferation significantly. Proliferation rate of HCT116 was reduced to 47% at 72 hours after 40/μmol/L U0126 treatment. Cell cycle analysis showed that the percentage of phase G0/G1 cells significantly increased (P<0. 01) and the percentage of phase S cells decreased (P<0.01) after treatment with ERK-MAPK inhibitor. The expression of MSK1 and RSK2 reduced obviously in both of human colorectal cancer cell lines treated with U0126, which resulted in a 28% and 40% reduction of levels of MSK1 and RSK2 as compared with control HCT116 cells respectively,while no detectable change in the expression of MSK2 was found. Consistent with this, the expression level of histone H3 (ser10) phosphorylation was markedly down-regulated by ERK-MAPK inhibitor, and the related protein c-Fos expression decreased accordantly. Conclusions Decreased ERK-MAPK signaling pathway may reduce histone H3 (Ser10) phosphorylation via suppression of the activity of histone H3 kinase including MSK1 and RSK2, but not MSK2, consequently decrease the expression of c-Fos protein, which results in the inhibition of colorectal cancer cells proliferation.

Extracellular Signal-Regulated Kinase 8-Mediated C-Jun Phosphorylation Increases Tumorigenesis of Human Colon Cancer

Bidirectional Signals Transduced by TOPK-ERK Interaction Increase Tumorigenesis of HCT116 Colorectal Cancer Cells

Extracellular signal-regulated kinases modulate DNA damage response - a contributing factor to using MEK inhibitors in cancer therapy.

New Tumor Suppressor Cxxc Finger Protein 4 Inactivates Mitogen Activated Protein Kinase Signaling

Cdk3-Mediated C-Jun Phosphorylation At Ser63 And Ser73 Enhances Cell Transformation

The MAPK Signalling Pathways and Colorectal Cancer

The Effect of Extracellular Signal-Regulated Kinases Signaling Pathway Inhibition on Histone Phosphorylation and Gene Expression in Colorectal Canoer Cells

ERK/MAPK signalling pathway and tumorigenesis

Data from Cyclin-Dependent Kinase-3–Mediated C-Jun Phosphorylation at Ser63 and Ser73 Enhances Cell Transformation

ERK/MAPK Signalling Pathway and Tumorigenesis (Review)

ZNF582 overexpression restrains the progression of clear cell renal cell carcinoma by enhancing the binding of TJP2 and ERK2 and inhibiting ERK2 phosphorylation

Phosphorylation of intestine-specific homeobox by ERK1 modulates oncogenic activity and sorafenib resistance

ERK Promotes Tumorigenesis by Inhibiting FOXO3a Via MDM2-mediated Degradation.

[Effects of Extracellular Signal-Regulated Kinase/mitogen-Activated Protein Kinase Signaling Pathway Activation on Proliferation and Cell Cycle Associated Genes in Human Colon Cancer Cells].

Effect of MSK1 and RSK2 Mediated Histone Phosphorylation on Malignant Phenotype of Human Colorectal Cancer Cells

The Mitogen-Activated Protein Kinase ERK5 Regulates the Development and Growth of Hepatocellular Carcinoma.

Molecular basis of the effect of midkine on tumor growth in human gastric cancer cell BGC823

ERK2 Is a Promoter of Cancer Cell Growth and Migration in Colon Adenocarcinoma

Ciliogenesis-associated Kinase 1 Promotes Breast Cancer Cell Proliferation and Chemoresistance Via Phosphorylating ERK1

The promotion of non‐small cell lung cancer progression by collagen and calcium binding EGF domain 1 is mediated through the regulation of ERK/JNK/P38 phosphorylation by reactive oxygen species

Sustained C-Jun-nh2-kinase Activity Promotes Epithelial-Mesenchymal Transition, Invasion, and Survival of Breast Cancer Cells by Regulating Extracellular Signal-Regulated Kinase Activation.